Figure 1

Serum hyaluronic acid (HA) levels in dengue subgroups: (a) Acute serum HA in non-dengue and all dengue patients (median, IQR), (b) Acute serum HA in non-dengue, DF and DHF subgroups (median, IQR), (c) Acute serum HA in patients with dengue primary and secondary infection (median, IQR), (d) Acute serum HA with respect to day of illness (first day of illness is defined as the day of fever onset; median, IQR).